Revenue
2018
2019
2020
2021
2022
2023
2024
2025
PureTech Health plc (PRTC)
Price£1.22Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7M | $4.8M | $3.3M | $15.6M | $17.4M | $11.8M | $9.8M | $20.7M |
| Research & development | $45.7M | $69.5M | $96.2M | $152.4M | $110.5M | $81.9M | $85.8M | $77.4M |
| Operating expenses | $103.2M | $140.9M | $149.5M | $213.4M | $167.7M | $131.3M | $145.2M | $124.8M |
| Operating income | −$98.5M | −$136.1M | −$146.2M | −$197.8M | −$150.3M | −$119.5M | −$135.4M | −$104.0M |
| Operating margin | −2,114.72% | −2,818.87% | −4,390.36% | −1,266.53% | −864.29% | −1,015.73% | −1,380.64% | −501.34% |
| EBITDA | −$61.8M | −$132.5M | −$141.3M | −$188.9M | −$143.0M | −$112.9M | −$128.7M | −$101.2M |
| EBITDA margin | −1,326.49% | −2,744.90% | −4,242.22% | −1,209.59% | −822.38% | −959.26% | −1,312.67% | −487.96% |
| Net income | −$109.7M | $27.8M | −$66.6M | −$37.1M | −$62.7M | $4.6M | $366.1M | −$70.7M |
| Net profit margin | −2,355.42% | 575.43% | −2,000.84% | −237.32% | −360.65% | 38.82% | 3,732.69% | −340.56% |
| Basic EPSper basic share | -$0.46 | $0.21 | -$0.24 | -$0.18 | -$0.21 | $0.02 | $1.49 | -$0.16 |
| Diluted EPSper diluted share | -$0.46 | $0.21 | -$0.24 | -$0.18 | -$0.21 | $0.02 | $1.44 | -$0.16 |